Latest Articles
1st patient dosed in trial of Enhertu for HER2 endometrial cancer - Rare Cancer News
1st patient dosed in trial of Enhertu for HER2 endometrial cancer Rare Cancer News
Published: June 18, 2025, 4:01 p.m.
Endometrial Cancer Treatment Market Overview With Key USA Updates and Global Outlook - openPR.com
Endometrial Cancer Treatment Market Overview With Key USA Updates and Global Outlook openPR.com
Published: June 18, 2025, 7:49 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - MSN
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer MSN
Published: June 16, 2025, 11:46 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Insider Monkey
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer Insider Monkey
Published: June 15, 2025, 9:42 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Yahoo
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer Yahoo
Published: June 15, 2025, 9:39 a.m.
S2 Episode 6: Sequencing Antibody-Drug Conjugates in Endometrial Cancer - Medscape
S2 Episode 6: Sequencing Antibody-Drug Conjugates in Endometrial Cancer Medscape
Published: June 12, 2025, 1:50 p.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Yahoo
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Yahoo
Published: June 10, 2025, 9:47 a.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Clinical Trials Arena
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Clinical Trials Arena
Published: June 10, 2025, 9:06 a.m.
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - Physician's Weekly
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer Physician's Weekly
Published: June 10, 2025, 6:31 a.m.
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - HealthDay
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer HealthDay
Published: June 9, 2025, 2:50 p.m.
Link copied to clipboard!